Anti-PD-L1 checkpoint inhibitors: Decoding the mystery

July 24, 2019 | City of Hope

An study conducted by Michael Caligiuri, M.D., and Jianhua Yu, Ph.D., unveiled why anti-PD-L1 monoclonal antibodies (mAb) are still effective in fighting tumors that lack PD-L1 receptors on their cells.

Continue Reading

City of Hope scientist receives $9.28M for CAR T trial for metastatic breast cancer

August 15, 2019 | Letisia Marquez

Saul Priceman, Ph.D., and his research team have received a $9.28 million award from the California Institute for Regenerative Medicine to support a CAR T cell phase 1 clinical trial for the treatment of women with HER2-positive breast cancer that has spread to the brain.

Researcher Awarded $3M Grant to Study Genomics of Breast Cancer in Latinas

August 14, 2019 | Jenny Peters

City of Hope researcher Susan Neuhausen, Ph.D., is studying genomic breast cancer risk among Latinas. The research is vital, as Latinas are underrepresented in studies of breast cancer and genetic risk assessment.

Blood test could predict breast cancer relapse

July 8, 2019 | Zen Vuong

A special blood test may one day predict if a newly diagnosed breast cancer patient will likely relapse years later, a City of Hope study suggests.

From Oranges, a Powerful Potential Cancer Fighter

June 13, 2019 | Wayne Lewis

Sharad Singhal, Ph.D., research professor in the Department of Medical Oncology and Therapeutics Research, leads investigations focusing on a small molecule that is abundant in the pith of citrus fruit.

Researchers detail new findings at 2019 AACR meeting

March 28, 2019 | Zen Vuong

City of Hope will showcase ongoing studies and data on chimeric antigen receptor (CAR) T cell therapy, immunotherapy against solid tumors and more at the American Association for Cancer Research annual meeting from March 29 through April 3 in Atlanta.

Can breast implants cause cancer?

November 30, 2018 | Samantha Bonar

Leslie Popplewell, M.D., discusses a recent NBC News report that highlighted the small but apparently growing risk of a rare kind of lymphoma in women who have received breast implants.